Get started
Author

Daniella J. Perlroth

Observed names: D. J. Perlroth, D. Perlroth, Daniella Perlroth, Daniella J. Perlroth
Institution: Stanford University
OpenAlex ID: A5049095992
Health Outcomes and Costs of Community Mitigation Strategies for an Influenza Pandemic in the United States
2009 · Daniella J. Perlroth, Robert J. Glass, et al. · Clinical Infectious Diseases · 77
PDF
School Nurses' Role in Asthma Management, School Absenteeism, and Cost Savings: A Demonstration Project
2013 · Eunice Rodriguez, Diana Austria Rivera, et al. · Journal of School Health · 70
Effectiveness and Cost-effectiveness of Thrombolysis in Submassive Pulmonary Embolism
2007 · Daniella J. Perlroth · Archives of Internal Medicine · 47
The potential impact of comparative effectiveness research on U.S. Health Care expenditures
2010 · Daniella J. Perlroth, Dana P. Goldman, et al. · Demography · 32
An Economic Analysis of Conservative Management Versus Active Treatment for Men with Localized Prostate Cancer
2012 · D. J. Perlroth, J. Bhattacharya, et al. · JNCI Monographs · 21
Effects of a Community-Based Fall Management Program on Medicare Cost Savings
2015 · Ekta Ghimire, Erin M. Colligan, et al. · American Journal of Preventive Medicine · 12
Can Oral Nutritional Supplements Improve Medicare Patient Outcomes in the Hospital?
2014 · Darius N. Lakdawalla, Julia Thornton Snider, et al. · Forum for Health Economics & Policy · 12
Time to ADT and chemotherapy initiation for treatment of metastatic prostate cancer (mPC).
2012 · Daniella J. Perlroth, Stephen F. Thompson, et al. · Journal of Clinical Oncology · 2
Treating people right: Who goes untreated with systemic therapy for metastatic prostate cancer (mPC)?
2012 · Daniella J. Perlroth, Stephen F. Thompson, et al. · Journal of Clinical Oncology · 2
Effect of Oral Nutritional Supplements On Hospital Outcomes in Patients Aged 65+ With Congestive Heart Failure
2014 · D. Lakdawalla, Snider J. Thornton, et al. · Value in Health · 1
Medical Care Costs of Patients with Amyotrophic Lateral Sclerosis in the Medicare Program (P07.065)
2013 · Daniella Perlroth, Dana Goldman, et al. · Neurology
Regional variation in survival after metastatic prostate cancer diagnosis
2012 · Darius Lakdawalla, Charu Gupta, et al. · F1000Research
Regional variation in survival after metastatic prostate cancer diagnosis.
2012 · Darius Lakdawalla, Charu Gupta, et al. · Journal of Clinical Oncology
Opportunity for all? Socioeconomic disparities in chemotherapy (CT) use for metastatic prostate cancer (mPC).
2012 · Daniella Perlroth, Yesenia L Luna, et al. · Journal of Clinical Oncology
Timing is everything: time to ADT and chemotherapy initiation for treatment of metastatic prostate cancer
2012 · Daniella Perlroth, Stephen F. Thompson, et al. · F1000Research
Treating people right: who goes untreated with systemic therapy for metastatic prostate cancer (mPC)?
2012 · Daniella Perlroth, Yesenia Luna, et al. · F1000Research
The Value of Progress against Cancer in the Elderly
2012 · Jay Bhattacharya, Alan M. Garber, et al. · University of Chicago Press eBooks
Investigations in the Economics of Aging
· Jay Bhattacharya, Alan M. Garber, et al. · RePEc: Research Papers in Economics
PDF
Works count: 18
Citation count: 276
H-index: 7
I10-index: 7
Year
Topic
Type